Agenus vs Alector
AGEN and ALEC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AGEN and ALEC compare
Agenus and Alector are about the same size, with market caps of $283M and $286M.
Agenus grew revenue faster over the last twelve months (30.5% versus −82.9% for Alector).
Agenus scores higher on the StockData Score (3 against 1 for Alector), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AGEN | ALEC |
|---|---|---|
| Size and price | ||
| Market cap | $283M | $286M |
| Share price | $6.29 | $2.56 |
| Change, 1 year | 45.3% | 106% |
| Change, 5 years | −90.3% | −87.1% |
| Beta (5Y) | 1.01 | 1.91 |
| Employees | 81 | 103 |
| StockData Score | ||
| Total score | 3 (better) | 1 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 0 | 1 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.1× (better) | 20.6× |
| EV/EBITDA | 7.0× | – |
| FCF yield | −34.8% (better) | −55.4% |
| Growth | ||
| Revenue growth (TTM) | 30.5% (better) | −82.9% |
| Revenue growth, 5Y average | 5.3% (better) | −0.05% |
| Profitability | ||
| Gross margin | 99.5% | – |
| Operating margin | 27.3% (better) | −912% |
| Net margin | – | −850% |
| FCF margin | −74.2% (better) | −1143% |
| Return on equity | – | −385% |
| Financial health | ||
| Net debt / EBITDA | 0.28 | – |
| Interest coverage | 0.6× | – |
| Current ratio | 0.34 | 5.26 (better) |
| Altman Z-score | −16.54 | −7.35 (better) |
| Piotroski F-score | – | 1 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 31.7% | 85.8% |
| Held by insiders | 6.6% | 9.6% |
| Insider net buying, 12 months | – | −$1.0M |
| Short interest, % of float | 18.1% | 8.3% |
Go deeper
- AGEN stock overview
- AGEN income statement
- AGEN valuation and score
- ALEC stock overview
- ALEC income statement
- ALEC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.